M&A Deal Summary

Carlin Acquires Infirst

On October 24, 2023, Carlin acquired healthcare services company Infirst

Acquisition Highlights
  • This is Carlin’s 1st transaction in the Healthcare Services sector.
  • This is Carlin’s 1st transaction in the United States.
  • This is Carlin’s 1st transaction in Connecticut.

M&A Deal Summary
Date 2023-10-24
Target Infirst
Sector Healthcare Services
Buyer(s) Carlin
Deal Type Add-on Acquisition

Target

Infirst

Westport, Connecticut, United States
Infirst is the marketer of two digestive health brands, Mylanta and Mylicon, pursuant to a trademark licensing agreement with McNeil Consumer Pharmaceuticals Co. Infirst is based in Westport, Connecticut.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Carlin

New York City, New York, United States
Category Company
Founded 2022
Sector Business Services
DESCRIPTION

Carlin is a consumer health business uniquely positioned to acquire leading over-the-counter brands. It was formed by leading sponsors, Hildred Capital Management, Bourne Partners Strategic Capital, and The Emerson Group, and initially acquired a leading acid reducer brand, Zegerid OTC. Carlin was formed in 2022 and is based in New York City.

DEAL STATS #
Overall 1 of 2
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Connecticut) 1 of 1
Country (United States) 1 of 2
Year (2023) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-04-30 Penetrex

San Diego, California, United States

Penetrex is an operator of a joint & muscle relief and recovery brand with a unique, deep penetrating, and therapeutic formulation trusted by millions of consumers. Penetrex was founded in 2008 and is based in San Diego, California.

Buy -
Mergr

Product

Company

Legal